Delta Organic Cannabis (DOC) is a privately held, Toronto-based cannabis investment company whose primary asset is an equity participation and earn-in agreement with CSE-listed Agraflora Organics International Inc. (AGRA). Under the Earn-In Agreement DOC is backing development of a 2.2 million square foot commercial medical cannabis cultivation operation in Delta, British Columbia, and will receive a 20% direct interest in the facility. The retrofit is divided into three phases: Phase 1 (350,000 sq ft, completion scheduled Q1 2019), Phase 2 (1,450,000 sq ft, by Q4 2019) and a final 400,000 sq ft phase; initial retrofit activities include site preparation, propagation operations, SOP development, security audit and ordering long‑lead items. Financially, DOC has advanced $12,500,000 to acquire 27,863,775 common shares of AGRA and is committed to advance a further $27,500,000 for an additional 61,300,305 AGRA common shares under the Earn‑In Agreement. Q Investments announced a $7,500,000 strategic private placement into DOC, which will be used to fund the second tranche of DOC’s investment into AGRA.

Total raised

$8M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2018